What is Regenxbio's AOCI?

Regenxbio (RGNX) reported AOCI of -$870K in Q1 2026.

How has Regenxbio's AOCI changed year-over-year?

Regenxbio's AOCI decreased by 14.2% year-over-year, from -$762K to -$870K.

What is the long-term trend for Regenxbio's AOCI?

Over 5 years (2020 to 2025), Regenxbio's AOCI has grown at a 13.8% compound annual growth rate (CAGR), from -$360K to -$687K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Regenxbio RGNX AOCI

AOCI at other companies

Regeneron PharmaceuticalsREGN

$11.9M-59.1%

Sarepta Therapeutics, Inc.SRPT

-$121K-456%

BiogenBIIB

-$140.2M+19.7%

BioMarin PharmaceuticalsBMRN

-$4.24M-122%

EyePoint, Inc. EYPT

$802K-13.1%

Ultragenyx PharmaceuticalRARE

$0+100%

Other financials

Income statement

See full

Revenue$6.4M-92.8%

Gross profit$14.9M+35.7%

Operating income-$83.4M-787%

Net income-$90.1M-1,580%

EPS (diluted)-$1.72-1,533%

Balance sheet

See full

Cash & equivalents$15.2M-88.3%

Total debt$71.1M-11.0%

Total equity$21.1M-92.3%

Total assets$341.9M-30.4%

Cash flow

See full

Operating cash flow-$76.2M-327%

CapEx$1.2M+20.6%

Free cash flow-$77.4M-337%

Valuation

See full

Market cap$529.38M+24.6%

Enterprise value$585.22M+56.3%

P/S6×+3.3×

Profitability

See full

Gross margin59.7%+1.0pp

Operating margin-292.3%-613pp

Net margin-330.2%-588pp

FCF margin-269.2%-364pp

Returns & leverage

See full

Return on equity-196.4%-288pp

Debt / equity3.4×+3.1×

Current ratio2.6×-0.3×

Where this comes from

Reported directly by Regenxbio in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regenxbio's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regenxbio's AOCI?: Regenxbio (RGNX) reported AOCI of -$870K in Q1 2026.
How has Regenxbio's AOCI changed year-over-year?: Regenxbio's AOCI decreased by 14.2% year-over-year, from -$762K to -$870K.
What is the long-term trend for Regenxbio's AOCI?: Over 5 years (2020 to 2025), Regenxbio's AOCI has grown at a 13.8% compound annual growth rate (CAGR), from -$360K to -$687K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.